STOCK TITAN

Indivior SEC Filings

INDV Nasdaq

Welcome to our dedicated page for Indivior SEC filings (Ticker: INDV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Indivior’s filings rarely start with simple numbers—they dive straight into opioid-treatment revenues, clinical-trial minutiae, and litigation updates that can sway valuations overnight. Finding the paragraph that explains patent expiry or the table that breaks out Suboxone sales often means scrolling through hundreds of pages. Stock Titan condenses those complexities into clear takeaways, so you can grasp material events without forensic reading.

Need the latest Indivior quarterly earnings report 10-Q filing or its blockbuster annual report 10-K simplified? They’re here, updated from EDGAR in real time and paired with AI text that translates accounting language into plain English. Our engine pinpoints opioid settlement provisions, breaks down regional sales trends, and flags any Indivior 8-K material events explained within minutes of release. You’ll also find Indivior insider trading Form 4 transactions—each alert showing executive stock movements, with context from past patterns.

Curious about governance? The Indivior proxy statement executive compensation is parsed to show pay structures and performance metrics, while Indivior Form 4 insider transactions real-time dashboards highlight buying or selling before FDA milestones. Add in side-by-side comparisons, keyword search, and downloadable tables, and you have the tools to perform fast Indivior earnings report filing analysis. Whether you’re understanding Indivior SEC documents with AI for the first time or refining an existing model, Stock Titan delivers every filing type—10-K, 10-Q, 8-K, S-1, and more—complete, searchable, and explained simply.

Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.7%
Tags
current report
-
Filing
Rhea-AI Summary

Form 144 notice for Indivior PLC (INDV): The filer notifies a proposed sale of 26,463 shares of Class A common stock through Merrill Lynch on 09/08/2025 with an aggregate market value of $655,000. The filing lists prior acquisitions of the shares: 13,805 shares bought on 03/26/2015 and 12,658 shares on 08/06/2019, both acquired on the open market for cash. The form also discloses sales by the same person within the past three months: 52,320 shares sold on 08/28/2025 for $1,278,178 and 30,000 shares sold on 09/04/2025 for $744,009.60. The filer certifies no undisclosed material adverse information and includes the required signature attestation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Indivior PLC insider Mark Crossley filed a Form 144 notifying the proposed sale of 183,938 Class A common shares through J.P. Morgan Securities LLC on the NYSE, with an aggregate market value of $4,593,150.74 and an approximate sale date of 09/08/2025. The securities were acquired on 03/09/2025 upon vesting of restricted stock units from Indivior PLC (243,282 units). The filing also discloses two recent sales by the same individual: 52,320 shares sold on 08/28/2025 for $1,278,178 and 30,000 shares sold on 09/04/2025 for $744,009.60. The notice includes the standard representation that the seller is unaware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Two Seas Capital (and related persons) reported beneficial ownership of 10,329,152 Ordinary Shares of Indivior plc, representing approximately 8.3% of the company's outstanding shares. These shares are held directly by two funds (the "Litigation Fund" and the "Global Fund") and TSC has sole voting and investment power over the securities pursuant to Investment Management Agreements. Aggregate purchase prices disclosed are approximately $38,987,296 for 6,311,887 shares held by the Litigation Fund and $45,107,871 for 4,017,265 shares held by the Global Fund. The Litigation Fund purchases were financed in part by a Credit Facility provided by UBS AG, London Branch. The filing also notes the Global Fund no longer holds any cash-settled swap positions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Form 144 notice for Indivior PLC (INDV) shows a proposed sale of 30,000 Class A common shares09/04/2025 with an aggregate market value of $744,009.60. The filer reports acquiring 243,282 shares on 03/09/2025 by vesting of restricted stock units issued by Indivior PLC, paid as equity compensation. The filing also discloses a prior sale within the past three months: 52,320 shares sold on 08/28/2025 for gross proceeds of $1,278,178, attributed to Mark Crossley c/o Indivior PLC. The form includes a representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Summary

Indivior PLC (INDV) submitted a Form 144 reporting a proposed sale of Class A common stock. The notice lists 52,320 shares to be sold through J.P. Morgan Securities LLC with an aggregate market value of $1,278,178 and an approximate sale date of 08/28/2025 on the NYSE. The filing shows these shares were acquired by vesting of restricted stock units: 243,282 shares vested on 03/09/2025 and 9,974 shares vested on 03/16/2025, both through equity compensation from Indivior PLC. The filer reports 124,769,536 shares outstanding and indicates there were no securities sold in the past three months by the selling person. The form includes the standard seller representation regarding absence of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Summary

Indivior PLC announced a three-phase operational plan—the Indivior Action Agenda—focused on generating momentum through 2025 by growing SUBLOCADE in the U.S., simplifying the organization, and accelerating long-acting injectable penetration and SUBLOCADE net revenue thereafter. On August 26, 2025 the company began Phase 1 initiatives that include headcount reductions, real estate consolidations, and consulting, legal, and tax planning. Indivior estimates $39–$50 million of pre-tax restructuring charges (about $27–$35 million cash) to be recognized in Q3 and Q4 2025 and says it will exclude these charges from non-GAAP measures. The company is also exploring strategic alternatives for OPVEE and its non-U.S. business; further one-time costs and savings could result. Estimates are subject to change based on assumptions and execution.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

Indivior PLC announced it entered into a new U.S.-style Employment Agreement and a Confidentiality, Proprietary Rights and Non-Competition Agreement with its Chief Financial Officer, Ryan Preblick, replacing his prior 2020 agreement. The company states there were no changes to his compensation, responsibilities, or title. The agreement specifies an annual base salary of $558,819, an annual cash bonus opportunity targeted at 60% of base salary (with a maximum opportunity of 120%), and potential long-term incentive awards with a grant-date value anticipated at 400% of base salary, subject to the Compensation Committee's discretion. The full agreements are filed as Exhibit 10.1 and Exhibit 10.2 and are incorporated by reference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Filing
Rhea-AI Summary

The filing reports that The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC jointly beneficially own 9,789,169 ordinary shares of Indivior PLC, representing approximately 7.8% of the class. The statement shows shared voting power of 9,789,144 shares and shared dispositive power of 9,789,169 shares, with no sole voting or sole dispositive power reported.

Exhibits identify the GS Group as a parent holding company and Goldman Sachs & Co. LLC as a broker-dealer and registered investment adviser. The filing includes a joint filing agreement and a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control. The statement provides ownership disclosure but does not disclose acquisition terms or strategic plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Indivior (INDV)?

The current stock price of Indivior (INDV) is $23.17 as of October 3, 2025.

What is the market cap of Indivior (INDV)?

The market cap of Indivior (INDV) is approximately 2.9B.
Indivior

Nasdaq:INDV

INDV Rankings

INDV Stock Data

2.90B
119.93M
3.88%
88.1%
6.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SLOUGH, BERKSHIRE